Cano Health Cash on Hand 2020-2024 | CANOQ
Cano Health cash on hand from 2020 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
|
Cano Health Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2023 | $94 |
| 2022 | $27 |
| 2021 | $163 |
| 2020 | $34 |
| 2019 | |
|
Cano Health Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2024-03-31 | $179 |
| 2023-12-31 | $94 |
| 2023-09-30 | $41 |
| 2023-06-30 | $28 |
| 2023-03-31 | $45 |
| 2022-12-31 | $27 |
| 2022-09-30 | $24 |
| 2022-06-30 | $48 |
| 2022-03-31 | $113 |
| 2021-12-31 | $163 |
| 2021-09-30 | $209 |
| 2021-06-30 | $319 |
| 2021-03-31 | $0 |
| 2020-12-31 | $34 |
| 2020-09-30 | $2 |
| 2020-06-30 | $2 |
| 2020-03-31 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.000B | $3.138B |
| Cano Health Inc. is a value-based primary care provider for seniors and underserved communities. It provides health management programs including telehealth, prescription home delivery, wellness programs, transition of care and high-risk and complex care management. Cano Health Inc., formerly known as Jaws Acquisition Corp., is based in MIAMI. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $165.999B | 30.48 |
| HCA Healthcare (HCA) | United States | $107.452B | 17.79 |
| CVS Health (CVS) | United States | $105.376B | 12.12 |
| Elevance Health (ELV) | United States | $82.464B | 12.09 |
| Cencora (COR) | United States | $68.573B | 22.11 |
| Natera (NTRA) | United States | $33.416B | 0.00 |
| DiDi Global (DIDIY) | China | $23.344B | 21.57 |
| Labcorp Holdings (LH) | United States | $22.106B | 16.86 |
| Medpace Holdings (MEDP) | United States | $16.564B | 41.12 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.437B | 0.00 |
| Viatris (VTRS) | United States | $15.215B | 5.67 |
| ICON (ICLR) | Ireland | $15.077B | 14.96 |
| BioMerieux (BMXMF) | France | $14.360B | 0.00 |
| Solventum (SOLV) | United States | $13.687B | 13.28 |
| Revvity (RVTY) | United States | $13.234B | 24.37 |
| CochLear (CHEOY) | Australia | $12.390B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.808B | 20.82 |
| Avantor (AVTR) | United States | $8.045B | 12.29 |
| Sonic Healthcare (SKHHY) | Australia | $7.967B | 0.00 |
| HealthEquity (HQY) | United States | $7.186B | 26.87 |
| BrightSpring Health Services (BTSG) | United States | $7.149B | 42.62 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.054B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.014B | 39.49 |
| PACS (PACS) | United States | $5.477B | 33.30 |
| Sotera Health (SHC) | United States | $5.259B | 25.36 |
| Alignment Healthcare (ALHC) | United States | $4.764B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $2.930B | 51.45 |
| Concentras Parent (CON) | United States | $2.762B | 17.24 |
| Organon (OGN) | United States | $2.537B | 2.67 |
| Progyny (PGNY) | United States | $2.174B | 42.75 |
| Surgery Partners (SGRY) | United States | $2.088B | 26.90 |
| Establishment Labs Holdings (ESTA) | United States | $1.916B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.850B | 11.05 |
| Ardent Health (ARDT) | United States | $1.226B | 4.00 |
| Teladoc Health (TDOC) | United States | $1.123B | 0.00 |
| Nutex Health (NUTX) | United States | $1.105B | 8.45 |
| CareDx (CDNA) | United States | $1.050B | 17.16 |
| Omada Health (OMDA) | United States | $0.957B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.869B | 14.22 |
| InnovAge Holding (INNV) | United States | $0.791B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.688B | 0.00 |
| Embecta (EMBC) | United States | $0.648B | 3.68 |
| Sonida Senior Living (SNDA) | United States | $0.592B | 0.00 |
| Enhabit (EHAB) | United States | $0.546B | 24.52 |
| CryoPort (CYRX) | United States | $0.520B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.472B | 0.00 |
| SBC Medicals (SBC) | United States | $0.448B | 8.25 |
| Auna S.A (AUNA) | Luxembourg | $0.419B | 6.74 |
| Agilon Health (AGL) | United States | $0.411B | 0.00 |
| Oncology Institute (TOI) | United States | $0.328B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.320B | 67.24 |
| Shoulder Innovations (SI) | United States | $0.307B | 0.00 |
| So-Young (SY) | China | $0.291B | 0.00 |
| Beauty Health (SKIN) | United States | $0.195B | 0.00 |
| KindlyMD (NAKA) | United States | $0.177B | 0.00 |
| LifeMD (LFMD) | United States | $0.172B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.135B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.125B | 0.00 |
| Biodesix (BDSX) | United States | $0.093B | 0.00 |
| DocGo (DCGO) | United States | $0.082B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.079B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.044B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.043B | 0.00 |
| Pomdoctor - (POM) | China | $0.029B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.021B | 6.41 |
| OSR Holdings (OSRH) | United States | $0.021B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.015B | 0.00 |
| Lifeward (LFWD) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |